Aptamer Group signs development and licensing deal with global life sciences partner
Scancell expands Phase 2 SCOPE trial with new intradermal dosing arm for iSCIB1+
Telix Pharmaceuticals delivers first commercial doses from Belgian manufacturing hub
CivicaScript introduces low-cost multiple sclerosis treatment
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Hemab Therapeutics presents bleeding disorder clinical and preclinical data at ISTH 2025 Congress
Stockholders approve proposed merger of TuHURA Biosciences and Kineta
BrightGene presents BGM0504 positive Phase 2 data for weight management and type 2 diabetes
Cumberland Pharmaceuticals reports ifetroban Phase 2 DMD heart disease trial results
Amgen reports results of Phase 2 MariTide obesity study
Teva Pharmaceutical Industries reports positive final results from PEARL migraine study
Merck reports positive Phase 3 results for WINREVAIR in pulmonary arterial hypertension